ScholarLens Back to search
2021•Journal of Allergy and Clinical ImmunologyRequires access

Basophil Activation Marker Selection, CD63 or CD203c, Improves Sensitivity of Basophil Activation Test Depending on the Clinical Entity in Immediate Allergic Reactions to Betalactams

Rubén Fernández‐Santamaría, Gador Bogas Herrera, María Salas, Adriana Ariza Veguillas, Ana Molina Bueno, Cristobalina Mayorga, Maria Torres Jaén, Tahía D. Fernández

Open publisher page 1 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Basophil activation, CD63, Basophil, Medicine, Anaphylaxis, Immunology, Allergy, Pharmacology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Basophil Activation Marker Selection, CD63 or CD203c, Improves Sensitivity of Basophil Activation Test Depending on the Clinical Entity in Immediate Allergic Reactions to Betalactams — Research Paper | ScholarLens